-
公开(公告)号:DE69730345T2
公开(公告)日:2005-09-22
申请号:DE69730345
申请日:1997-12-03
Applicant: CELLTECH R&D LTD
Inventor: WARRELLOW GRAHAM JOHN , BROWN JULIEN ALISTAIR
IPC: A61K31/4409 , A61P1/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/12 , A61P17/06 , A61P37/08 , A61P43/00 , C07D213/38 , C07D213/53 , C07D213/89 , A61K31/44
-
22.
公开(公告)号:ZA200305372B
公开(公告)日:2004-07-12
申请号:ZA200305372
申请日:2003-07-11
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: A61P20060101 , C07C20060101 , C07D20060101 , C07D , A61P , C07C
-
23.
公开(公告)号:SK10322003A3
公开(公告)日:2004-02-03
申请号:SK10322003
申请日:2002-01-18
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/81 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07C229/36
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R 1 , R x , R y , R z , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
公开(公告)号:DE60315032D1
公开(公告)日:2007-08-30
申请号:DE60315032
申请日:2003-07-16
Applicant: CELLTECH R&D LTD
Inventor: BROWN JULIEN ALISTAIR , BAILEY STUART , BRAND STEPHEN
IPC: C07D471/04 , A61K31/4375 , A61K31/496 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P9/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/06 , A61P43/00 , C07D221/00
Abstract: Phenylalanine enamide derivatives of formula (1) are described:wherein R is a -CH(CH3)2, -(CH2)2CH3, -CH2C(CH3)3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2OH, -CH2CH2OCH2CH2OCH3,group; and the salts, solvates and N-oxides thereof.Compounds according to the invention are potent and selective inhibitors of alpha4 integrins. The compounds are of use in modulating cell adhesion and in particular are of use in the prophylaxis and treatment of diseases or disorders including inflammation in which the extravasation of leukocytes plays a role and the invention extends to such a use and to the use of the compounds for the manufacture of a medicament for treating such diseases or disorders.
-
公开(公告)号:PT1370531E
公开(公告)日:2007-04-30
申请号:PT02715515
申请日:2002-01-18
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: C07D213/81 , A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/36 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04
-
26.
公开(公告)号:PL364142A1
公开(公告)日:2004-12-13
申请号:PL36414202
申请日:2002-01-18
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/81 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R 1 , R x , R y , R z , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
公开(公告)号:AT273955T
公开(公告)日:2004-09-15
申请号:AT97947166
申请日:1997-12-03
Applicant: CELLTECH R&D LTD
Inventor: WARRELLOW GRAHAM JOHN , BROWN JULIEN ALISTAIR
IPC: A61K31/4409 , A61P1/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P13/12 , A61P17/06 , A61P37/08 , A61P43/00 , C07D213/38 , C07D213/53 , C07D213/89 , A61K31/44
-
28.
公开(公告)号:AU2003281162A1
公开(公告)日:2004-02-02
申请号:AU2003281162
申请日:2003-07-16
Applicant: CELLTECH R&D LTD
Inventor: BROWN JULIEN ALISTAIR , BAILEY STUART , BRAND STEPHEN
IPC: A61K31/4409 , A61P1/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P11/06 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/06 , C07D213/81 , A61K31/44
Abstract: Phenylalanine enamide derivatives of formula (1) are described:wherein R is a -CH3, -(CH2)3CH3, -CH2CH2OH, -CH2CH2OCH3, -CH2CH2OCH2CH2OH, -CH2CH2OCH2CH2OCH3,group;and the salts, solvates and N-oxides thereof.Compounds according to the invention are potent and selective inhibitors of alpha4 integrins. The compounds are of use in modulating cell adhesion and in particular are of use in the prophylaxis and treatment of diseases or disorders including inflammation in which the extravasation of leukocytes plays a role and the invention extends to such a use and to the use of the compounds for the manufacture of a medicament for treating such diseases or disorders.
-
29.
公开(公告)号:CZ20032259A3
公开(公告)日:2004-01-14
申请号:CZ20032259
申请日:2002-01-18
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/81 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07C229/36 , A61K31/435
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R 1 , R x , R y , R z , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
30.
公开(公告)号:GB2387845A
公开(公告)日:2003-10-29
申请号:GB0318429
申请日:2002-01-18
Applicant: CELLTECH R&D LTD
Inventor: BAILEY STUART , BROWN JULIEN ALISTAIR , BRAND STEPHEN , JOHNSON JAMES ANDREW , PORTER JOHN ROBERT , HEAD JOHN CLIFFORD
IPC: A61K31/198 , A61K31/4375 , A61K31/44 , A61K31/4406 , A61K31/497 , A61P3/10 , A61P9/00 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P29/00 , A61P37/00 , A61P37/06 , A61P43/00 , C07C229/34 , C07C229/46 , C07C233/82 , C07C321/22 , C07C323/30 , C07D213/81 , C07D213/89 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07C229/36
Abstract: Phenylalanine enamide derivatives of formula (1) are described: wherein R , R , R , R , X and V are as defined in claim 1. The compounds are able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders or disorders involving the inappropriate growth or migration of cells.
-
-
-
-
-
-
-
-
-